Virpax Pharmaceuticals Inc.
13F holders, Q4 2024 (December 31)12holders +3
4new positions
3sold out
$0.37avg. 13F price*
At the end of Q4 2024, 12 institutions reported holding Virpax Pharmaceuticals Inc. in their 13F filings, up 3 from Q3 2024. 4 opened new positions and 3 sold out. The largest holders were Geode Capital Management, LLC ($15K), Virtu Financial LLC ($9K) and HRT Financial LP ($9K).
- Company
- Virpax Pharmaceuticals Inc.
- CUSIP
- 928251206
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $23K |
| Exits | 3 | $31K |
All 13F filers, Q3 2024 → Q4 2024: 80,527 shares bought and 51,289 shares sold, net +29,238 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Geode Capital Management, LLC | 0.00% | Add +49.8% | 41,899 | $15K |
| Virtu Financial LLC | 0.00% | New | 23,657 | $9K |
| HRT Financial LP | 0.00% | New | 25,368 | $9K |
| UBS Group AG | 0.00% | Reduce -35.9% | 13,100 | $5K |
| XTX Topco Ltd | 0.00% | New | 12,905 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +102.1% | 7,754 | $3K |
| SBI Securities Co., Ltd. | 0.00% | — | 600 | $228 |
| Morgan Stanley | 0.00% | Add +3226.7% | 499 | $190 |
| Osaic Holdings, Inc. | 0.00% | New | 240 | $91 |
| Vermillion Wealth Management, Inc. | 0.00% | — | 100 | $38 |
| Bank of America Corp. | 0.00% | Add +75.7% | 65 | $25 |
| Hantz Financial Services, Inc. | 0.00% | No change | 10 | $0 |
"% of holder's portfolio" is VIRPAX PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Virpax Pharmaceuticals Inc. the manager owns.